ISSN:
2181-3906
2024
International scientific journal
«MODERN
SCIENCE
АND RESEARCH»
VOLUME 3 / ISSUE 2 / UIF:8.2 / MODERNSCIENCE.UZ
436
ORIGIN, TREATMENT, PREVENTION OF ITSENKO-CUSHING SYNDROME
IN MODERN INTERPRETATION.
Rakhmonova Laylo
Najmiddinova Muhlisa
Usmanova Marjona
Nabiyeva Nigina
Samarkand State Medical University
Students of the Department of Endocrinology!
https://doi.org/10.5281/zenodo.10653329
Abstract. Cushing's syndrome is a pathological condition of the div characterized by an
excessive amount of the hormone cortisol produced by the adrenal glands. The main cause of the
disease is the disruption of regulatory mechanisms responsible for the functioning of the
hypothalamus-pituitary-adrenal system.
The disease can appear at any age; can be congenital or acquired. The main symptoms of
the disease: disorder of fat metabolism, destruction of bone tissue, damage to the heart and blood
vessels, high blood glucose levels, mental disorders.
Key words: Cushing's syndrome, types of Itsenko-Cushing's syndrome, other symptoms of
endocrine disease.
ПРОИСХОЖДЕНИЕ, ЛЕЧЕНИЕ, ПРОФИЛАКТИКА СИНДРОМА ИЦЕНКО-
КУШИНГА В СОВРЕМЕННОЙ ИНТЕРПРЕТАЦИИ
Аннотация. Синдром Кушинга – патологическое состояние организма,
характеризующееся избыточным количеством гормона кортизола, вырабатываемого
надпочечниками. Основной причиной заболевания является нарушение регуляторных
механизмов, отвечающих за функционирование гипоталамо-гипофизарно-надпочечниковой
системы.
Заболевание может появиться в любом возрасте; может быть врожденным или
приобретенным. Основные симптомы заболевания: нарушение жирового обмена,
разрушение костной ткани, поражение сердца и сосудов, повышенный уровень глюкозы в
крови, психические расстройства.
Ключевые слова: синдром Кушинга, разновидности синдрома Иценко-Кушинга,
другие симптомы эндокринных заболеваний.
If not treated, Cushing's syndrome causes serious life-threatening complications: heart or
lung failure, renal hypertension, frequent bone fractures, myopathy, etc. Therefore, at the first signs
of pathology, an experienced endocrinologist should be contacted.
Itsenko-Cushing syndrome is a pathological condition caused by excessive production of
the hormone cortisol by the cortex of the adrenal glands or long-term use of glucocorticoid drugs.
In women, the pathology is 10 times more frequent than in men, and in most cases it develops at
the age of 25-40. Taking into account the effect on absolutely all div systems, without treatment,
the symptoms of Cushing's syndrome are constantly increasing, which leads to irreversible
consequences and life-threatening complications.
Types of Itsenko-Cushing syndrome
ISSN:
2181-3906
2024
International scientific journal
«MODERN
SCIENCE
АND RESEARCH»
VOLUME 3 / ISSUE 2 / UIF:8.2 / MODERNSCIENCE.UZ
437
Symptoms of Itsenko-Cushing syndrome directly depend on the form of the pathology. It
can be classified as follows.
endogenous: related to excessive production of cortisol by the div;
exogenous: caused by taking glucocorticoid drugs.
Depending on the level of ACTH:
Dependent on ACTH: develops due to excessive production of the substance;
ACTH-independent: Caused by spontaneous oversecretion of cortisol.
When diagnosing Itsenko-Cushing syndrome, it is very important to accurately determine
the form, because the treatment tactics depend on it.
Symptoms of Cushing's syndrome
The main symptom of Cushing's syndrome is severe obesity. At the same time, excess div
weight is unevenly distributed - fat accumulates in the face, neck, chest, back and abdomen. Limbs
tend to become thinner. The face is moon-shaped, with feverish purple-red redness and acne.
1.
Other symptoms of endocrine disease:
2.
muscle atrophy, muscle weakness;
3.
fragility of the bone skeleton, tendency to fracture;
4.
bad posture (kyphosis, scoliosis);
5.
pale skin, clearly visible vascular pattern;
6.
bright stretch marks (stretch marks) on the abdomen, chest and buttocks;
7.
high blood pressure;
8.
arrhythmia;
9.
decreased vision;
10.
frequent headaches;
11.
menstrual disorders;
12.
sexual dysfunction,
13.
quick fatigue;
14.
prone to neuroses.
Causes of Cushing's syndrome
Adrenal glands are enlarged in Cushing's syndrome. As a result, the glands begin to secrete
a large amount of corticosteroid hormones, which provokes the typical symptoms of the disease.
The main causes of the development of Cushing's syndrome:
•
genetic predisposition;
•
the presence of a pituitary adenoma;
•
tumor formation of the adrenal cortex;
•
oncological processes of other organs - lungs, pancreas;
•
past infections affecting the central nervous system (meningitis, influenza);
•
traumatic brain injury;
•
intoxication of the div;
•
hormonal imbalance (for example, during pregnancy or menopause);
•
long-term use of drugs containing glucocorticoids.
•
Treatment methods for Cushing's syndrome
ISSN:
2181-3906
2024
International scientific journal
«MODERN
SCIENCE
АND RESEARCH»
VOLUME 3 / ISSUE 2 / UIF:8.2 / MODERNSCIENCE.UZ
438
Therapeutic treatment
The main goal of therapeutic treatment is to eliminate the mechanism of excess production
of adrenal hormones, normalize the level of cortisol in the div, and eliminate the unpleasant
symptoms of the disease. For this, first of all, the doctor gives the patient the necessary
recommendations for lifestyle changes - following a low-calorie diet and increasing physical
activity.
Drug therapy includes the use of the following drugs:
•
drugs that suppress the production of hormones by the adrenal cortex;
•
drugs that lower blood sugar;
•
diuretics;
•
cardiac glycosides;
•
antidepressants or tranquilizers;
•
Treatment for Cushing's syndrome includes radiation therapy and chemotherapy. These
methods allow to achieve good therapeutic results in the fight against pathology.
Surgery
In most cases, Cushing's syndrome develops due to tumor growth, which must be surgically
removed. Surgical treatment is performed using modern minimally invasive methods. The use of
high-tech equipment allows our specialists to eliminate the pathology almost bloodlessly, without
affecting nearby tissues.
REFERENCES
1.
Andryev S. et al. Experience with the use of memantine in the treatment of cognitive
disorders //Science and innovation. – 2023. – Т. 2. – №. D11. – С. 282-288.
2.
Antsiborov S. et al. Association of dopaminergic receptors of peripheral blood
lymphocytes with a risk of developing antipsychotic extrapyramidal diseases //Science and
innovation. – 2023. – Т. 2. – №. D11. – С. 29-35.
3.
Farrukh S. ORGANIZATION OF DIGITALIZED MEDICINE AND HEALTH
ACADEMY AND ITS SIGNIFICANCE IN MEDICINE //Science and innovation. – 2023.
– Т. 2. – №. Special Issue 8. – С. 493-499.
4.
Asanova R. et al. Features of the treatment of patients with mental disorders and
cardiovascular pathology //Science and innovation.
– 2023. – Т. 2. – №. D12. – С. 545-550.
5.
Begbudiyev M. et al. Integration of psychiatric care into primary care //Science and
innovation. – 2023. – Т. 2. – №. D12. – С. 551-557.
6.
Bo’Riyev B. et al. Features of clinical and psychopathological examination of young
children //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 558-563.
7.
Borisova Y. et al. Concomitant mental disorders and social functioning of adults with high-
functioning autism/asperger syndrome //Science and innovation. – 2023. – Т. 2. – №. D11.
– С. 36-41.
8.
Farrukh S. ORGANIZATION OF DIGITALIZED MEDICINE AND HEALTH
ACADEMY AND ITS SIGNIFICANCE IN MEDICINE //Science and innovation. – 2023.
– Т. 2. – №. Special Issue 8. – С. 493-499.
ISSN:
2181-3906
2024
International scientific journal
«MODERN
SCIENCE
АND RESEARCH»
VOLUME 3 / ISSUE 2 / UIF:8.2 / MODERNSCIENCE.UZ
439
9.
Ivanovich U. A. et al. Efficacy and tolerance of pharmacotherapy with antidepressants in
non-psychotic depressions in combination with chronic brain ischemia //Science and
Innovation. – 2023. – Т. 2. – №. 12. – С. 409-414.
10.
Karshiyev Z. et al. The degree of adaptation to psychogenic effects in social life in patients
with psychogenic asthma //Science and innovation.
– 2023. – Т. 2. – №. D11. – С. 295-302.
11.
Konstantinova O. et al. Clinical and psychological characteristics of patients with
alcoholism with suicidal behavior //Science and innovation. – 2023. – Т. 2. – №. D11. – С.
399-404.
12.
Konstantinova O. et al. Experience in the use of thiamine (vitamin B1) megadose in the
treatment of korsakov-type alcoholic encephalopathy //Science and innovation. – 2023. –
Т. 2. – №. D12. – С. 564-570.
13.
Kosolapov V. et al. Modern strategies to help children and adolescents with anorexia
nervosa syndrome //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 571-575.
14.
Farrukh S. ORGANIZATION OF DIGITALIZED MEDICINE AND HEALTH
ACADEMY AND ITS SIGNIFICANCE IN MEDICINE //Science and innovation. – 2023.
– Т. 2. – №. Special Issue 8. – С. 493-499.
15.
Lomakin S. et al. Biopsychosocial model of internet-dependent behavior. Risk factors for
the formation of the internet //Science and innovation.
– 2023. – Т. 2. – №. D12. – С. 205-211.
16.
Lomakin S. et al. Features of electroencephalographic disorders in patients with mental
disorders due to brain damage or dysfunction //Science and innovation. – 2023. – Т. 2. –
№. D12. – С. 367-372.
17.
Farrukh S. ORGANIZATION OF DIGITALIZED MEDICINE AND HEALTH
ACADEMY AND ITS SIGNIFICANCE IN MEDICINE //Science and innovation. – 2023.
– Т. 2. – №. Special Issue 8. – С. 493-499.
18.
Lomakin S. et al. Socio-demographic, personal and clinical characteristics of relatives of
patients with alcoholism //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 278-283.
19.
Lukasheva A. et al. Psychosomatic relationships in different age groups in patients with
facial dermatosis //Science and innovation. – 2023. – Т. 2. – №. D11. – С. 289-294.
